Company / Operating Cash Flow per Share
Charles River Laboratories Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$14.99
FY2025
5-year range
$9.66 / $14.99
FY2021-FY2025
Trend
+4.7%
vs FY2024
Sector context
#18 of 162
Health Care
What the data says
Charles River Laboratories's operating cash flow per share of $14.99 is higher than 89% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $6.60 in FY2019 to $14.99 in FY2025.
Based on SEC 10-K filings.
14.99 in FY2025 with a 5-year CAGR of +10.7%. Top quartile in the Health Care sector.
Remained stable around $14.99 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +11.4%
- 5-Year CAGR
- +10.7%
- 10-Year CAGR
- -
Sector benchmark
+126.0% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 4.7% year-over-year.
- Ranks #18 out of 162 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.99 | +4.7% |
| FY2024 | $14.31 | -4.2% |
| FY2023 | $14.93 | +37.9% |
| FY2022 | $10.83 | +12.0% |
| FY2021 | $9.66 | +7.2% |
| FY2020 | $9.01 | +36.6% |
| FY2019 | $6.60 | -29.1% |
| FY2018 | $9.31 | +38.6% |
| FY2017 | $6.72 | -1.0% |
| FY2016 | $6.79 | +53.6% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026